PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Gasparin, F. ; Tietje, M.R.* ; Katab, E.* ; Nurdinova, A. ; Yuan, T. ; Chmyrov, A. ; Uluc, N. ; Jüstel, D. ; Bassermann, F.* ; Ntziachristos, V. ; Pleitez, M.A.

Label-free protein-structure-sensitive live-cell microscopy for patient-specific assessment of myeloma therapy.

Nat. Bio. Eng., DOI: 10.1038/s41551-025-01443-3 (2025)
Publ. Version/Full Text Research data DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
The efficacy of drug therapy in multiple myeloma is conventionally assessed by whole-cell-population methods, serum analysis of light chains and monoclonal antibodies, immunofixation electrophoresis, or by flow cytometry of bone marrow aspirates and biopsies. These methods provide relevant information on the presence of specific immunoglobulins at high sensitivity and specificity but require a large number of cells, involve long and laborious sample preparation steps, and provide only tumour bulk information. Here we develop a single-cell imaging technique requiring a reduced number of primary cells for longitudinal evaluation of patient-specific treatment and assessment of treatment heterogeneity. By exploiting the mechanistic action of proteasome inhibition and in synergy with the label-free protein-structure specificity of mid-infrared optoacoustic microscopy, we present a technology that facilitates longitudinal evaluation of myeloma treatment and a patient's heterogeneous response. Detecting optical-generated ultrasound waves that intensify with optical absorption, this technology allows observation of proteins in living cells with high sensitivity. Specifically, we use intermolecular β-sheet formation as a biomarker for cell viability during therapy and apply it to assess drug-treatment performance in multiple myeloma patients.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Human Multiple-myeloma; Infrared-spectroscopy; Proteasome Inhibitors; Ir; Conformation; Bortezomib; Apoptosis
Language english
Publication Year 2025
HGF-reported in Year 2025
ISSN (print) / ISBN 2157-846X
e-ISSN 2157-846X
Journal Nature biomedical engineering
Publisher Nature Publishing Group
Publishing Place London ; New York NY ; Tokyo
Reviewing status Peer reviewed
Institute(s) Institute of Biological and Medical Imaging (IBMI)
Institute of Computational Biology (ICB)
POF-Topic(s) 30205 - Bioengineering and Digital Health
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-505500-001
G-505594-001
G-503800-001
Grants European Research Council (ERC) under the European Union
German Research Foundation)
Deutsche Forschungsgemeinschaft (DFG
Deutsche Forschungsgemeinschaft (German Research Foundation)
DOI 10.1038/s41551-025-01443-3
WOS ID 001528314900001
Scopus ID 105010638212
PubMed ID 40659832
Erfassungsdatum 2025-07-22
[➜Report correction]